Healthcare - Biotechnology - NASDAQ - US
$ 5.84
-5.96 %
$ 222 M
Market Cap
-3.74
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
77.24%
EBIT
Estimate
28.29%
Net Income
Estimate
8.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Orchestra BioMed Holdings, Inc.
OBIO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart OBIO
EBIT FORECAST
EBIT Forecast Chart OBIO
NET INCOME FORECAST
Net Income Chart OBIO